"The consensus price target fell 23% to AU$3.98, with the analysts clearly concerned about the company following the weaker revenue and earnings outlook"
"The most optimistic Mesoblast analyst has a price target of AU$5.80 per share, while the most pessimistic values it at AU$2.15"The consensus of $3.98 seems like an average of the two prices of $5.80 & $2.15 = 3.975.
The Bell Potter report which appears to be the $5.80 per share didn't seem concerned about the company earnings outlook, quite the contrary, that only leave the $2.15 report... hmmm where is that one?
Bell Potter Daily Pack 16 April 2020, page-22
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 99.0¢ | $1.03 | 97.0¢ | $2.815M | 2.838M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 151781 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 80522 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |